Pharmarise Holdings (TSE:2796) Total Stockholders Equity : 円7,872 Mil (As of Feb. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Pharmarise Holdings Total Stockholders Equity?

Pharmarise Holdings's Total Stockholders Equity for the quarter that ended in Feb. 2024 was 円7,872 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Pharmarise Holdings's Book Value per Share for the quarter that ended in Feb. 2024 was 円700.16. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Pharmarise Holdings's Debt-to-Equity for the quarter that ended in Feb. 2024 was 1.34.

Pharmarise Holdings Total Stockholders Equity Historical Data

The historical data trend for Pharmarise Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmarise Holdings Total Stockholders Equity Chart

Pharmarise Holdings Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Total Stockholders Equity

Get a 7-Day Free Trial

5,461.00

5,905.00

6,221.00

6,607.00

6,881.00

Pharmarise Holdings Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Total Stockholders Equity	Get a 7-Day Free Trial															6,732.00	6,881.00	6,872.00	8,310.00	7,872.00

Pharmarise Holdings (TSE:2796) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Pharmarise Holdings's Book Value per Share for the quarter that ended in Feb. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(7872	-	0)	/	11.2432
	=	700.16

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Pharmarise Holdings's Debt-to-Equity for the quarter that ended in Feb. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2263	+	8300)	/	7872
	=	1.34

Pharmarise Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Pharmarise Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmarise Holdings (TSE:2796) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharmarise Holdings Corp (TSE:2796) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011

Website

http://www.pharmarise.com

Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.

Pharmarise Holdings (TSE:2796) Headlines

No Headlines